Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study

by Ikuro Matsuba, Takehiro Kawata, Kotaro Iemitsu, Taro Asakura, Hikaru Amemiya, Masashi Ishikawa, Syogo Ito, Mizuki Kaneshiro, Akira Kanamori, Akira Kubota, Kazuaki Shinoda, Masahiko Takai, Tetsuo Takuma, Masahiro Takihata, Hiroshi Takeda, Keiji Tanaka, Yoko Matsuzawa, Hideo Machimura, Fuyuki Minagawa, Nobuaki Minami, Atsuko Mokubo, Masaaki Miyakawa, Yasuo Terauchi, Yasushi Tanaka
Published 2020-09-01

Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors

by Atsushi Goto, Hirofumi Go, Kei Miyakawa, Yutaro Yamaoka, Yutaro Yamaoka, Norihisa Ohtake, Norihisa Ohtake, Sousuke Kubo, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, Takahiro Mihara, Kotaro Senuki, Tomoyuki Miyazaki, Satoshi Ikeda, Takashi Ogura, Hideaki Kato, Ikuro Matsuba, Naoko Sanno, Masaaki Miyakawa, Haruo Ozaki, Masakazu Kikuoka, Yasuo Ohashi, Akihide Ryo, Takeharu Yamanaka, Takeharu Yamanaka
Published 2021-05-01